期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
多西他赛注射液血液平衡透析研究
1
作者 董美阳 许卉 +1 位作者 施亚琴 孙葭北 《药物分析杂志》 CAS CSCD 北大核心 2023年第4期636-643,共8页
目的:对4个品牌聚山梨酯-80药用辅料以及4个厂家多西他赛注射液中的聚山梨酯-80进行组分分析和比较,评价血液中聚山梨酯-80组分差异对其与多西他赛结合能力的影响。方法:采用Eclipse-XDB C_(18)(150 mm×4.6 mm,3.5μm)色谱柱,以乙... 目的:对4个品牌聚山梨酯-80药用辅料以及4个厂家多西他赛注射液中的聚山梨酯-80进行组分分析和比较,评价血液中聚山梨酯-80组分差异对其与多西他赛结合能力的影响。方法:采用Eclipse-XDB C_(18)(150 mm×4.6 mm,3.5μm)色谱柱,以乙腈-水(50∶50)为流动相A,四氢呋喃为流动相B梯度洗脱;采用HPLC-ELSD检测器对聚山梨酯-80进行组分分析,采用截留分子量为20 kD的纤维素酯透析膜进行血液平衡透析实验;使用Sunfire^(TM)C_(18)(150 mm×4.6 mm,5μm)色谱柱,以水-乙腈为流动相梯度洗脱测定多西他赛,考察聚山梨酯-80与药物的结合能力。结果:不同品牌的聚山梨酯-80药用辅料以及不同品牌多西他赛注射液中的聚山梨酯-80在组分上存在一定差异;血液平衡透析实验结果显示聚山梨酯-80对多西他赛的结合能力远小于血液成分与药物的结合能力,血液环境下聚山梨酯-80的组分差异对其与多西他赛结合能力的影响不明显;不同厂家多西他赛注射液中聚山梨酯-80对血液中多西他赛的结合能力差异不明显。结论:不同厂家多西他赛注射液中聚山梨酯-80对药物在血液中的分配没有显著影响,该研究结果较生理盐水中的透析实验结果更具有生物学意义。 展开更多
关键词 多西他赛注射液 聚山梨酯-80 药用辅料 组分分析 平衡透析 药物结合 注射液质量评价 蒸发光散射
原文传递
Holistic quality evaluation of Panax notoginseng extract and injection using an UPLC-QTOF-MS^E based metabolomics approach 被引量:5
2
作者 赵一懿 郭洪祝 +1 位作者 陈有根 傅欣彤 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2017年第5期335-345,共11页
In the present study, we established an UPLC-QTOF-MSE based metabolomic approach in order to evaluate the holistic qualities and compare the quality difference by finding characteristic components of Panax notoginseng... In the present study, we established an UPLC-QTOF-MSE based metabolomic approach in order to evaluate the holistic qualities and compare the quality difference by finding characteristic components of Panax notoginseng extracts (PNE) and Xuesaitong (XST) injection samples from different manufacturers. The data were processed through unsupervised principal component analysis (PCA) and supervised orthogonal partial least squared discrimination analysis (OPLS-DA) to compare the quality differences. Two-dimensional PCA score plots showed a tendency to separate the XST injections and extracts, and most XST injection samples were clearly clustered into two groups. Especially, the injections from He and YB companies were distinguished into two groups. In addition, only injection samples of Hu company were near the cluster of PNE. To explore the potential chemical components contributing most to the differences between XST injection samples from different manufacturers and PNE, an S-plot was constructed following the OPLS-DA. Ginsenoside Rd, ginsenoside Rgl, ginsenoside Re, ginsenoside Rbl, 20(S)-ginsenoside Rhl, gypenoside VII, ginsenoside Rg2, ginsenoside Rh4, ginsenoside Rkl or Rgs, notoginsenoside Fc, 20(R)-ginsenoside Rg3, ginsenoside F2 and protopanaxadiol were recognized as characteristic chemical markers that contributed most to reflect the difference between XST injections and PNE. Ginsenoside Rd, ginsenoside Rgl, ginsenoside Re, ginsenoside Rbl and gypenoside VII were revealed as index components contributing most to the differences of PNE and XST injections, and quantitative analysis of these components could ensure the consistent quality of XST injections. Based on the fact that the injections should be standardized with the characteristic components as quality control chemical markers, it is most important to keep the quality of extracts of raw materials stable and reliable. 展开更多
关键词 Panax notoginseng extract XST injection UPLC-QTOF-MSE Metabolomics Holistic quality evaluation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部